$KFRC
KFORCE INC

2022 Q1 Form 10-Q Financial Statement

#000093042022000112 Filed on May 04, 2022

View on sec.gov

Income Statement

Concept 2022 Q1 2021 Q4 2021 Q3
Revenue $417.0M $410.4M $402.7M
YoY Change 14.8% 15.9% 10.21%
Cost Of Revenue $293.1M $290.4M $283.5M
YoY Change 10.79% 14.5% 8.38%
Gross Profit $123.9M $120.0M $119.3M
YoY Change 25.54% 19.44% 14.81%
Gross Profit Margin 29.71% 29.24% 29.61%
Selling, General & Admin $95.05M $94.10M $88.97M
YoY Change 21.81% 25.3% 17.3%
% of Gross Profit 76.72% 78.43% 74.6%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $1.093M $1.080M $1.026M
YoY Change -9.07% -10.0% -21.08%
% of Gross Profit 0.88% 0.9% 0.86%
Operating Expenses $97.58M $95.18M $91.45M
YoY Change 21.19% 24.75% 17.09%
Operating Profit $27.74M $24.80M $29.27M
YoY Change 42.64% 2.66% 9.54%
Interest Expense -$608.0K -$761.0K -$750.0K
YoY Change -24.0% -15.44% -6.25%
% of Operating Profit -2.19% -3.07% -2.56%
Other Income/Expense, Net -$1.433M -$770.0K -$1.448M
YoY Change 11.52% 92.5% 54.37%
Pretax Income $26.31M $23.27M $27.82M
YoY Change 44.84% 1.62% 7.91%
Income Tax $7.130M $2.712M $7.650M
% Of Pretax Income 27.1% 11.65% 27.5%
Net Earnings $19.18M $20.56M $20.17M
YoY Change 44.64% 12.44% 7.49%
Net Earnings / Revenue 4.6% 5.01% 5.01%
Basic Earnings Per Share $0.94 $0.99
Diluted Earnings Per Share $0.93 $975.9K $0.96
COMMON SHARES
Basic Shares Outstanding 20.32M shares 21.42M shares 20.43M shares
Diluted Shares Outstanding 20.73M shares 21.10M shares

Balance Sheet

Concept 2022 Q1 2021 Q4 2021 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $116.6M $96.99M $115.6M
YoY Change 15.13% -6.29% 14.15%
Cash & Equivalents $116.6M $96.99M $115.6M
Short-Term Investments
Other Short-Term Assets $7.520M $6.790M $8.044M
YoY Change 8.99% -3.0% 8.7%
Inventory
Prepaid Expenses
Receivables $278.1M $265.3M $269.9M
Other Receivables $3.243M $3.010M $0.00
Total Short-Term Assets $405.5M $372.1M $393.6M
YoY Change 15.03% 9.8% 16.21%
LONG-TERM ASSETS
Property, Plant & Equipment $6.586M $5.964M $5.821M
YoY Change -75.03% -77.75% -78.96%
Goodwill $25.04M $25.04M $25.04M
YoY Change 0.0% 0.0% 0.0%
Intangibles
YoY Change
Long-Term Investments $16.68M $17.01M $15.78M
YoY Change 39.06% 62.17% 67.29%
Other Assets $92.41M $92.63M $88.07M
YoY Change 15.55% 19.41% 19.21%
Total Long-Term Assets $124.0M $131.3M $129.0M
YoY Change -11.96% -6.33% -7.52%
TOTAL ASSETS
Total Short-Term Assets $405.5M $372.1M $393.6M
Total Long-Term Assets $124.0M $131.3M $129.0M
Total Assets $529.5M $503.4M $522.6M
YoY Change 7.33% 5.08% 9.28%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $48.86M $40.24M $41.84M
YoY Change 69.95% 99.44% 75.96%
Accrued Expenses $41.47M $41.17M $36.15M
YoY Change 330.4% 168.08% 112.07%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $183.2M $160.4M $161.6M
YoY Change 45.89% 48.32% 26.45%
LONG-TERM LIABILITIES
Long-Term Debt $100.0M $100.0M $100.0M
YoY Change 0.0% 0.0% 0.0%
Other Long-Term Liabilities $47.43M $54.56M $71.08M
YoY Change -47.96% -40.01% -11.42%
Total Long-Term Liabilities $47.43M $54.56M $71.08M
YoY Change -47.96% -40.01% -11.42%
TOTAL LIABILITIES
Total Short-Term Liabilities $183.2M $160.4M $161.6M
Total Long-Term Liabilities $47.43M $54.56M $71.08M
Total Liabilities $331.3M $315.0M $332.7M
YoY Change 4.61% 5.31% 8.0%
SHAREHOLDERS EQUITY
Retained Earnings $455.4M $442.6M $427.6M
YoY Change 14.75% 13.88% 14.1%
Common Stock $730.0K $730.0K $726.0K
YoY Change 0.55% 0.55% 0.55%
Preferred Stock
YoY Change
Treasury Stock (at cost) $753.8M $743.6M $722.2M
YoY Change 8.67% 9.77% 7.56%
Treasury Stock Shares 51.64M shares 51.49M shares 51.21M shares
Shareholders Equity $198.2M $188.4M $190.0M
YoY Change
Total Liabilities & Shareholders Equity $529.5M $503.4M $522.6M
YoY Change 7.33% 5.08% 9.28%

Cashflow Statement

Concept 2022 Q1 2021 Q4 2021 Q3
OPERATING ACTIVITIES
Net Income $19.18M $20.56M $20.17M
YoY Change 44.64% 12.44% 7.49%
Depreciation, Depletion And Amortization $1.093M $1.080M $1.026M
YoY Change -9.07% -10.0% -21.08%
Cash From Operating Activities $38.74M $12.95M $23.37M
YoY Change 72.75% -15.33% -57.43%
INVESTING ACTIVITIES
Capital Expenditures $2.221M -$1.415M -$2.107M
YoY Change 64.52% 17.92% 40.47%
Acquisitions
YoY Change
Other Investing Activities -$500.0K -$2.000M -$2.500M
YoY Change -75.0% 33.33%
Cash From Investing Activities -$2.721M -$3.415M -$4.607M
YoY Change -18.78% 26.48% 207.13%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $10.27M
YoY Change -37.04%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -$16.38M -28.18M -20.41M
YoY Change -22.8% 170.98% 353.56%
NET CHANGE
Cash From Operating Activities $38.74M 12.95M 23.37M
Cash From Investing Activities -$2.721M -3.415M -4.607M
Cash From Financing Activities -$16.38M -28.18M -20.41M
Net Change In Cash $19.64M -18.64M -1.648M
YoY Change -1015.52% -947.36% -103.37%
FREE CASH FLOW
Cash From Operating Activities $38.74M $12.95M $23.37M
Capital Expenditures $2.221M -$1.415M -$2.107M
Free Cash Flow $36.52M $14.37M $25.48M
YoY Change 73.28% -12.91% -54.83%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q1 dei Amendment Flag
AmendmentFlag
false
CY2022Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2022Q1 dei Entity File Number
EntityFileNumber
000-26058
CY2022Q1 dei Entity Registrant Name
EntityRegistrantName
Kforce Inc
CY2022Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
FL
CY2022Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2022Q1 dei Entity Central Index Key
EntityCentralIndexKey
0000930420
CY2022Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022Q1 us-gaap Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List
OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2021-01-31#OtherAssetsNoncurrent
CY2022Q1 us-gaap Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List
OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesNoncurrent
CY2022Q1 dei Document Type
DocumentType
10-Q
CY2022Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2022Q1 dei Document Period End Date
DocumentPeriodEndDate
2022-03-31
CY2022Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
59-3264661
CY2022Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
1001 East Palm Avenue
CY2022Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Tampa
CY2022Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
FL
CY2022Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
33605
CY2022Q1 dei City Area Code
CityAreaCode
813
CY2022Q1 dei Local Phone Number
LocalPhoneNumber
552-5000
CY2022Q1 dei Security12b Title
Security12bTitle
Common Stock, $0.01 per share
CY2022Q1 dei Trading Symbol
TradingSymbol
KFRC
CY2022Q1 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2022Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022Q1 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2022Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2022Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2022Q1 dei Entity Shell Company
EntityShellCompany
false
CY2022Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
21384450 shares
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
416967000 USD
CY2021Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
363225000 USD
CY2022Q1 us-gaap Cost Of Revenue
CostOfRevenue
293081000 USD
CY2021Q1 us-gaap Cost Of Revenue
CostOfRevenue
264543000 USD
CY2022Q1 us-gaap Gross Profit
GrossProfit
123886000 USD
CY2021Q1 us-gaap Gross Profit
GrossProfit
98682000 USD
CY2022Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
95049000 USD
CY2021Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
78029000 USD
CY2022Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1093000 USD
CY2021Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1202000 USD
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
27744000 USD
CY2021Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
19451000 USD
CY2022Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-1433000 USD
CY2021Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-1285000 USD
CY2022Q1 us-gaap Income Loss Attributable To Parent
IncomeLossAttributableToParent
26311000 USD
CY2021Q1 us-gaap Income Loss Attributable To Parent
IncomeLossAttributableToParent
18166000 USD
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
7130000 USD
CY2021Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4905000 USD
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
19181000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
13261000 USD
CY2022Q1 us-gaap Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent
0 USD
CY2021Q1 us-gaap Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent
-47000 USD
CY2021Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax Parent
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent
939000 USD
CY2022Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
21483000 USD
CY2021Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
14247000 USD
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.94
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.63
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.93
CY2021Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.62
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20319000 shares
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20932000 shares
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
20730000 shares
CY2021Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
21361000 shares
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
116627000 USD
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
96989000 USD
CY2022Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
2520000 USD
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
2342000 USD
CY2022Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
278064000 USD
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
265322000 USD
CY2022Q1 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
3243000 USD
CY2021Q4 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
3010000 USD
CY2022Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
7520000 USD
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
6790000 USD
CY2022Q1 us-gaap Assets Current
AssetsCurrent
405454000 USD
CY2021Q4 us-gaap Assets Current
AssetsCurrent
372111000 USD
CY2022Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
6586000 USD
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
5964000 USD
CY2022Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
92414000 USD
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
92629000 USD
CY2022Q1 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
0 USD
CY2021Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
7657000 USD
CY2022Q1 us-gaap Goodwill
Goodwill
25040000 USD
CY2021Q4 us-gaap Goodwill
Goodwill
25040000 USD
CY2022Q1 us-gaap Assets
Assets
529494000 USD
CY2021Q4 us-gaap Assets
Assets
503401000 USD
CY2022Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
90328000 USD
CY2021Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
81408000 USD
CY2022Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
86629000 USD
CY2021Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
71424000 USD
CY2022Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
5447000 USD
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
6338000 USD
CY2022Q1 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
757000 USD
CY2021Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
1239000 USD
CY2022Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
37000 USD
CY2021Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
22000 USD
CY2022Q1 us-gaap Liabilities Current
LiabilitiesCurrent
183198000 USD
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
160431000 USD
CY2022Q1 us-gaap Long Term Line Of Credit
LongTermLineOfCredit
100000000 USD
CY2021Q4 us-gaap Long Term Line Of Credit
LongTermLineOfCredit
100000000 USD
CY2022Q1 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
665000 USD
CY2021Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
0 USD
CY2022Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
47426000 USD
CY2021Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
54564000 USD
CY2022Q1 us-gaap Liabilities
Liabilities
331289000 USD
CY2021Q4 us-gaap Liabilities
Liabilities
314995000 USD
CY2022Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2022Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
15000000 shares
CY2022Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
15000000 shares
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
455365000 USD
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
442596000 USD
CY2022Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000 shares
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000 shares
CY2022Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
72996000 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
72997000 shares
CY2022Q1 us-gaap Common Stock Value
CommonStockValue
730000 USD
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
730000 USD
CY2022Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
492985000 USD
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
488036000 USD
CY2022Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
2923000 USD
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
621000 USD
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
19181000 USD
CY2022Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
1000 USD
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
4437000 USD
CY2022Q1 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
242000 USD
CY2022Q1 us-gaap Treasury Stock Shares
TreasuryStockShares
51636000 shares
CY2021Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
51493000 shares
CY2022Q1 us-gaap Treasury Stock Value
TreasuryStockValue
753798000 USD
CY2021Q4 us-gaap Treasury Stock Value
TreasuryStockValue
743577000 USD
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
198205000 USD
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
188406000 USD
CY2022Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
529494000 USD
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
503401000 USD
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
188406000 USD
CY2021Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.30
CY2022Q1 us-gaap Dividends Common Stock
DividendsCommonStock
6094000 USD
CY2022Q1 us-gaap Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent
0 USD
CY2021Q3 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax
-780000 USD
CY2022Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax Parent
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent
2302000 USD
CY2022Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
10270000 USD
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
198205000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
179935000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
13261000 USD
CY2021Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
0 USD
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3403000 USD
CY2021Q1 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
170000 USD
CY2020Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.23
CY2021Q1 us-gaap Dividends Common Stock
DividendsCommonStock
4786000 USD
CY2021Q1 us-gaap Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent
-47000 USD
CY2020Q3 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax
-319000 USD
CY2021Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax Parent
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent
939000 USD
CY2021Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
16313000 USD
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
176656000 USD
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
19181000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
13261000 USD
CY2022Q1 us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
8321000 USD
CY2021Q1 us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
931000 USD
CY2022Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
172000 USD
CY2021Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-852000 USD
CY2022Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1093000 USD
CY2021Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1202000 USD
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
4437000 USD
CY2021Q1 us-gaap Share Based Compensation
ShareBasedCompensation
3403000 USD
CY2022Q1 us-gaap Pension And Other Postretirement Benefit Expense
PensionAndOtherPostretirementBenefitExpense
0 USD
CY2021Q1 us-gaap Pension And Other Postretirement Benefit Expense
PensionAndOtherPostretirementBenefitExpense
252000 USD
CY2022Q1 us-gaap Gain Loss On Sales Of Assets And Asset Impairment Charges
GainLossOnSalesOfAssetsAndAssetImpairmentCharges
-168000 USD
CY2021Q1 us-gaap Gain Loss On Sales Of Assets And Asset Impairment Charges
GainLossOnSalesOfAssetsAndAssetImpairmentCharges
0 USD
CY2022Q1 kfrc Noncash Lease Expense
NoncashLeaseExpense
1502000 USD
CY2021Q1 kfrc Noncash Lease Expense
NoncashLeaseExpense
1114000 USD
CY2022Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-825000 USD
CY2021Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-491000 USD
CY2022Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2221000 USD
CY2022Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-190000 USD
CY2021Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-242000 USD
CY2022Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
12914000 USD
CY2021Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
15001000 USD
CY2022Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
2577000 USD
CY2021Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
324000 USD
CY2022Q1 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
15447000 USD
CY2021Q1 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
12203000 USD
CY2022Q1 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
2897000 USD
CY2021Q1 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
5504000 USD
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
38742000 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
22426000 USD
CY2021Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1350000 USD
CY2022Q1 us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
500000 USD
CY2021Q1 us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
2000000 USD
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2721000 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-3350000 USD
CY2022Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
10270000 USD
CY2021Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
16313000 USD
CY2022Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
6094000 USD
CY2021Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
4786000 USD
CY2022Q1 us-gaap Repayments Of Debt And Capital Lease Obligations
RepaymentsOfDebtAndCapitalLeaseObligations
19000 USD
CY2021Q1 us-gaap Repayments Of Debt And Capital Lease Obligations
RepaymentsOfDebtAndCapitalLeaseObligations
122000 USD
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-16383000 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-21221000 USD
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
19638000 USD
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-2145000 USD
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
96989000 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
103486000 USD
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
116627000 USD
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
101341000 USD
CY2022Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
314000 USD
CY2021Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
332000 USD
CY2022Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
1812000 USD
CY2021Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
1690000 USD
CY2022Q1 us-gaap Interest Paid Net
InterestPaidNet
547000 USD
CY2021Q1 us-gaap Interest Paid Net
InterestPaidNet
634000 USD
CY2022Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
446000 USD
CY2021Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
243000 USD
CY2022Q1 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
242000 USD
CY2021Q1 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
170000 USD
CY2022Q1 us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-top:5pt"><span style="color:#004b8d;font-family:'Open Sans Light',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Open Sans Light',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. The most critical of these estimates and assumptions relate to the following: allowance for credit losses; income taxes; self-insured liabilities for health insurance; and the impairment of goodwill, other long-lived assets and the equity method investment. Although these and other estimates and assumptions are based on the best available information, actual results could be materially different from these estimates. In addition, the potential economic consequences of the COVID-19 pandemic, inflationary pressures, and supply constraints, among others, have been and may continue to be uncertain, rapidly changing and difficult to predict. Therefore, our accounting estimates and assumptions might change materially in future periods.</span></div>
CY2022Q1 kfrc Health Insurance Stop Loss Maximum Per Claim
HealthInsuranceStopLossMaximumPerClaim
600000 USD
CY2022Q1 kfrc Health Insurance Stop Loss Maximum Per Claim
HealthInsuranceStopLossMaximumPerClaim
600000 USD
CY2022Q1 kfrc Health Insurance Aggregate Risk Of Loss Liability Amount In Excess Of The Stop Loss Maximum
HealthInsuranceAggregateRiskOfLossLiabilityAmountInExcessOfTheStopLossMaximum
200000 USD
CY2022Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
411000 shares
CY2021Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
429000 shares
CY2022Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
305000 shares
CY2021Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0 shares
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
26311000 USD
CY2021Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
363225000 USD
CY2021Q1 us-gaap Gross Profit
GrossProfit
98682000 USD
CY2021Q1 us-gaap Operating Expenses
OperatingExpenses
80516000 USD
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
416967000 USD
CY2022Q1 us-gaap Gross Profit
GrossProfit
123886000 USD
CY2022Q1 us-gaap Operating Expenses
OperatingExpenses
97575000 USD
CY2021Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
18166000 USD
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
416967000 USD
CY2021Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
363225000 USD
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
1729000 USD
CY2022Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
172000 USD
CY2022Q1 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
78000 USD
CY2022Q1 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
1823000 USD
CY2022Q1 us-gaap Debt Issuance Costs Line Of Credit Arrangements Net
DebtIssuanceCostsLineOfCreditArrangementsNet
1057000 USD
CY2022Q1 kfrc Accounts Receivable Allowance For Credit Loss Allowance Unrelated To Trade Receivables
AccountsReceivableAllowanceForCreditLossAllowanceUnrelatedToTradeReceivables
700000 USD
CY2021Q4 kfrc Accounts Receivable Allowance For Credit Loss Allowance Unrelated To Trade Receivables
AccountsReceivableAllowanceForCreditLossAllowanceUnrelatedToTradeReceivables
600000 USD
CY2022Q1 us-gaap Deferred Compensation Plan Assets
DeferredCompensationPlanAssets
38213000 USD
CY2021Q4 us-gaap Deferred Compensation Plan Assets
DeferredCompensationPlanAssets
41607000 USD
CY2022Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
13376000 USD
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
15395000 USD
CY2022Q1 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
14796000 USD
CY2021Q4 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
14666000 USD
CY2022Q1 us-gaap Equity Method Investments
EquityMethodInvestments
16683000 USD
CY2021Q4 us-gaap Equity Method Investments
EquityMethodInvestments
17008000 USD
CY2021Q4 us-gaap Debt Issuance Costs Line Of Credit Arrangements Net
DebtIssuanceCostsLineOfCreditArrangementsNet
1115000 USD
CY2022Q1 us-gaap Derivative Assets Noncurrent
DerivativeAssetsNoncurrent
3905000 USD
CY2021Q4 us-gaap Derivative Assets Noncurrent
DerivativeAssetsNoncurrent
823000 USD
CY2022Q1 us-gaap Other Assets Miscellaneous Noncurrent
OtherAssetsMiscellaneousNoncurrent
4384000 USD
CY2021Q4 us-gaap Other Assets Miscellaneous Noncurrent
OtherAssetsMiscellaneousNoncurrent
2015000 USD
CY2022Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
92414000 USD
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
92629000 USD
CY2022Q1 us-gaap Capitalized Computer Software Accumulated Amortization
CapitalizedComputerSoftwareAccumulatedAmortization
35400000 USD
CY2021Q4 us-gaap Capitalized Computer Software Accumulated Amortization
CapitalizedComputerSoftwareAccumulatedAmortization
35500000 USD
CY2022Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
48855000 USD
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
40241000 USD
CY2022Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
41473000 USD
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
41167000 USD
CY2022Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
90328000 USD
CY2021Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
81408000 USD
CY2022Q1 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
51724000 USD
CY2021Q4 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
43738000 USD
CY2022Q1 us-gaap Accrued Insurance Current
AccruedInsuranceCurrent
29791000 USD
CY2021Q4 us-gaap Accrued Insurance Current
AccruedInsuranceCurrent
22466000 USD
CY2022Q1 us-gaap Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
4342000 USD
CY2021Q4 us-gaap Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
4474000 USD
CY2022Q1 us-gaap Workers Compensation Liability Current
WorkersCompensationLiabilityCurrent
772000 USD
CY2021Q4 us-gaap Workers Compensation Liability Current
WorkersCompensationLiabilityCurrent
746000 USD
CY2022Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
86629000 USD
CY2021Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
71424000 USD
CY2022Q1 kfrc Number Of Executives Supplemental Executive Retirement Plan
NumberOfExecutivesSupplementalExecutiveRetirementPlan
2 executive
CY2022Q1 us-gaap Pension And Other Postretirement Defined Benefit Plans Current Liabilities
PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities
20000000 USD
CY2021Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3400000 USD
CY2022Q1 us-gaap Deferred Compensation Liability Classified Noncurrent
DeferredCompensationLiabilityClassifiedNoncurrent
37273000 USD
CY2021Q4 us-gaap Deferred Compensation Liability Classified Noncurrent
DeferredCompensationLiabilityClassifiedNoncurrent
42623000 USD
CY2022Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
10136000 USD
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
11919000 USD
CY2022Q1 us-gaap Other Sundry Liabilities Noncurrent
OtherSundryLiabilitiesNoncurrent
17000 USD
CY2021Q4 us-gaap Other Sundry Liabilities Noncurrent
OtherSundryLiabilitiesNoncurrent
22000 USD
CY2022Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
47426000 USD
CY2021Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
54564000 USD
CY2022Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
4400000 USD
CY2022Q1 kfrc Supplemental Unemployment Benefits On Change In Control
SupplementalUnemploymentBenefitsOnChangeInControl
38200000 USD
CY2022Q1 kfrc Supplemental Unemployment Benefits On No Change In Control
SupplementalUnemploymentBenefitsOnNoChangeInControl
13700000 USD
CY2022Q1 kfrc Equity Method Investment Capital Commitment Maximum
EquityMethodInvestmentCapitalCommitmentMaximum
22500000 USD
CY2022Q1 kfrc Advances To Equity Method Investment To Date
AdvancesToEquityMethodInvestmentToDate
22500000 USD

Files In Submission

Name View Source Status
0000930420-22-000112-index-headers.html Edgar Link pending
0000930420-22-000112-index.html Edgar Link pending
0000930420-22-000112.txt Edgar Link pending
0000930420-22-000112-xbrl.zip Edgar Link pending
exhibit311q12022.htm Edgar Link pending
exhibit312q12022.htm Edgar Link pending
exhibit321q12022.htm Edgar Link pending
exhibit322q12022.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
kfrc-20220331.htm Edgar Link pending
kfrc-20220331.xsd Edgar Link pending
kfrc-20220331_cal.xml Edgar Link unprocessable
kfrc-20220331_def.xml Edgar Link unprocessable
kfrc-20220331_g1.jpg Edgar Link pending
kfrc-20220331_htm.xml Edgar Link completed
kfrc-20220331_lab.xml Edgar Link unprocessable
kfrc-20220331_pre.xml Edgar Link unprocessable
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending